ArticleThe International journal on drug policy2022

Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing.

Kim Corace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.